Stock listing

Rohto Pharmaceutical Co., Ltd.

Selected listing: UC1 · GETTEX · EUR · DE

Rohto Pharmaceutical Co., Ltd. (gettex:UC1), Consumer Non-Durables. Latest release Oct 5, 2026: Notice Regarding Partial Corrections to “Medium- to Long-Term…

UC1:GETTEXEURDEUpdated September 26, 2026

Ticker: gettex:UC1
Asset type: Stock
Sector: Consumer Non-Durables
Industry: Household/Personal Care
Exchange: gettex
Currency: EUR

Latest news from Rohto Pharmaceutical Co., Ltd.

Notice Regarding Partial Corrections to “Medium- to Long-Term Growth Strategy 2026”

October 5, 2026

Medium- to Long-Term Growth Strategy 2026,October 5, 2026

October 5, 2026

Medium- to Long-Term Growth Strategy 2026

October 1, 2026

Management Strategy Briefing

October 1, 2026

Rohto Pharmaceutical : バージャー病、膠原病により生じる難治性虚血性（非動脈硬化性）下肢潰瘍に対するRE-01細胞治療の第II相医師主導治験を開始

September 15, 2026

All Rohto Pharmaceutical Co., Ltd. news →

Research Rohto Pharmaceutical Co., Ltd.

Rohto Pharmaceutical Co., Ltd. company profile

View the public company page for Rohto Pharmaceutical Co., Ltd. on 6ix.

Rohto Pharmaceutical Co., Ltd. news

Read company news and market updates connected to Rohto Pharmaceutical Co., Ltd..

Rohto Pharmaceutical Co., Ltd. investor events

Find investor webinars, events, and replay context for Rohto Pharmaceutical Co., Ltd..